SG11201504572WA - Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration - Google Patents
Chloroprocaine-based pharmaceutical composition for repeated intrathecal administrationInfo
- Publication number
- SG11201504572WA SG11201504572WA SG11201504572WA SG11201504572WA SG11201504572WA SG 11201504572W A SG11201504572W A SG 11201504572WA SG 11201504572W A SG11201504572W A SG 11201504572WA SG 11201504572W A SG11201504572W A SG 11201504572WA SG 11201504572W A SG11201504572W A SG 11201504572WA
- Authority
- SG
- Singapore
- Prior art keywords
- chloroprocaine
- pharmaceutical composition
- intrathecal administration
- based pharmaceutical
- repeated intrathecal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002120A ITMI20122120A1 (en) | 2012-12-12 | 2012-12-12 | PHARMACEUTICAL COMPOSITION BASED ON CHLOROPROCAIN FOR REPEATED INTRATECAL ADMINISTRATION |
| PCT/IB2013/060801 WO2014091420A1 (en) | 2012-12-12 | 2013-12-11 | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504572WA true SG11201504572WA (en) | 2015-07-30 |
Family
ID=47633206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504572WA SG11201504572WA (en) | 2012-12-12 | 2013-12-11 | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9504666B2 (en) |
| KR (1) | KR102162587B1 (en) |
| CN (1) | CN105283222A (en) |
| AR (1) | AR099443A1 (en) |
| AU (1) | AU2013356855B2 (en) |
| IL (1) | IL239270B (en) |
| IT (1) | ITMI20122120A1 (en) |
| MX (1) | MX2015007288A (en) |
| MY (1) | MY180957A (en) |
| NZ (1) | NZ709631A (en) |
| PH (1) | PH12015501313B1 (en) |
| RU (1) | RU2648823C2 (en) |
| SG (1) | SG11201504572WA (en) |
| UA (1) | UA115078C2 (en) |
| WO (1) | WO2014091420A1 (en) |
| ZA (1) | ZA201504618B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111494310A (en) * | 2020-04-29 | 2020-08-07 | 周晓玲 | Preparation and application method of local anesthetic |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006513224A (en) * | 2002-12-20 | 2006-04-20 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ | Ester local anesthetic combinations |
| ITMI20051633A1 (en) * | 2005-09-06 | 2007-03-07 | Sint Sa | NEW USE OF A COMPOSITION INCLUDING CHOROPROCAINE HCL NEW COMPOSITION INCLUDING CHLOROPROCAINE HCL AND METHOD FOR ITS MANUFACTURING |
-
2012
- 2012-12-12 IT IT002120A patent/ITMI20122120A1/en unknown
-
2013
- 2013-12-09 AR ARP130104578A patent/AR099443A1/en unknown
- 2013-12-11 WO PCT/IB2013/060801 patent/WO2014091420A1/en active Application Filing
- 2013-12-11 MX MX2015007288A patent/MX2015007288A/en unknown
- 2013-12-11 AU AU2013356855A patent/AU2013356855B2/en active Active
- 2013-12-11 KR KR1020157018300A patent/KR102162587B1/en active IP Right Grant
- 2013-12-11 RU RU2015128024A patent/RU2648823C2/en active
- 2013-12-11 MY MYPI2015701905A patent/MY180957A/en unknown
- 2013-12-11 NZ NZ709631A patent/NZ709631A/en unknown
- 2013-12-11 CN CN201380065146.8A patent/CN105283222A/en active Pending
- 2013-12-11 UA UAA201506088A patent/UA115078C2/en unknown
- 2013-12-11 SG SG11201504572WA patent/SG11201504572WA/en unknown
- 2013-12-11 US US14/650,583 patent/US9504666B2/en active Active
-
2015
- 2015-06-07 IL IL239270A patent/IL239270B/en active IP Right Grant
- 2015-06-09 PH PH12015501313A patent/PH12015501313B1/en unknown
- 2015-06-25 ZA ZA2015/04618A patent/ZA201504618B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015128024A (en) | 2017-01-18 |
| AU2013356855B2 (en) | 2018-02-15 |
| IL239270B (en) | 2018-03-29 |
| ITMI20122120A1 (en) | 2014-06-13 |
| AU2013356855A1 (en) | 2015-07-23 |
| PH12015501313A1 (en) | 2015-08-24 |
| KR20150085131A (en) | 2015-07-22 |
| RU2648823C2 (en) | 2018-03-28 |
| MX2015007288A (en) | 2015-09-10 |
| UA115078C2 (en) | 2017-09-11 |
| AR099443A1 (en) | 2016-07-27 |
| ZA201504618B (en) | 2019-01-30 |
| CN105283222A (en) | 2016-01-27 |
| KR102162587B1 (en) | 2020-10-08 |
| WO2014091420A1 (en) | 2014-06-19 |
| IL239270A0 (en) | 2015-07-30 |
| PH12015501313B1 (en) | 2015-08-24 |
| US20150320716A1 (en) | 2015-11-12 |
| US9504666B2 (en) | 2016-11-29 |
| MY180957A (en) | 2020-12-14 |
| NZ709631A (en) | 2020-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1209638A1 (en) | Pharmaceutical compositions | |
| ZA201501930B (en) | Pharmaceutical composition | |
| EP2832730A4 (en) | Mirabegron-containing pharmaceutical composition | |
| HK1199821A1 (en) | Oral pharmaceutical composition | |
| HK1199822A1 (en) | Oral pharmaceutical composition | |
| ZA201405797B (en) | Pharmaceutical dosage form | |
| AP2015008208A0 (en) | Pharmaceutical administration forms comprising | |
| HK1205683A1 (en) | Pharmaceutical formulation having improved stability | |
| PL2908837T3 (en) | Compositions for drug delivery | |
| ZA201502987B (en) | Pharmaceutical composition | |
| EP2897590A4 (en) | Pharmaceutical composition | |
| EP2851074A4 (en) | Analgesic pharmaceutical composition | |
| GB201211153D0 (en) | Pharmaceutical compositions | |
| ZA201504618B (en) | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration | |
| HK1209339A1 (en) | Pharmaceutical formulations | |
| EP2851078A4 (en) | Pharmaceutical composition | |
| EP2873422A4 (en) | Pharmaceutical preparation for injection | |
| IL238075A0 (en) | Pharmaceutical compositions | |
| ZA201502354B (en) | Pharmaceutical dosage form | |
| ZA201400751B (en) | Pharmaceutical composition | |
| GB201219234D0 (en) | Pharmaceutical compositions | |
| GB201213303D0 (en) | Pharmaceutical compositions | |
| GB201204810D0 (en) | Pharmaceutical compositions | |
| GB201221130D0 (en) | New pharmaceutical composition | |
| GB201207628D0 (en) | New pharmaceutical composition |